FDA expands Pfizer vaccine鈥檚 booster authorization to include 16- and 17-year-olds; CDC recommends
The Food and Drug Administration today the widely anticipated expansion of Pfizer鈥檚 COVID-19 vaccine emergency use authorization to allow booster doses for 16- and 17-year-olds. The FDA said boosters for this age group should be administered at least six months following the completion of an initial two-dose regiment. Following FDA鈥檚 decision, the Centers for Disease Control and Prevention formally recommended boosters for this age group.
鈥淲e know that COVID-19 vaccines are safe and effective, and I strongly encourage adolescents ages 16 and 17 to get their booster if they are at least 6 months post their initial Pfizer vaccination series,鈥 said CDC Director Rochelle Walensky, M.D.
Related News Articles
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥
Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.鈥檚 nomination for secretary of the Department of Health and Human Services. A鈥
Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu鈥
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers鈥
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability鈥
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the鈥